Evopoint Biosciences Co., Ltd. (SHA:688837)
China · Delayed Price · Currency is CNY 49.40
+5.79 (13.28%)
Sep 30, 2026, 3:00 PM CST
Evopoint Biosciences Market Cap
Evopoint Biosciences has a market cap or net worth of 21.51 billion as of October 2, 2026.
Market Cap
21.51B
Enterprise Value
21.82B
Revenue
1.11B
Ranking
n/a
PE Ratio
44.71
Stock Price
49.40
ChartMarket Cap Chart
Since September 16, 2026, Evopoint Biosciences's market cap has increased from 17.50B to 21.51B, an increase of 22.95%. That is a compound annual growth rate of 21,729.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 21.51B | 13.28% |
| Sep 29, 2026 | 18.99B | -3.24% |
| Sep 28, 2026 | 19.63B | -4.73% |
| Sep 24, 2026 | 20.60B | -11.74% |
| Sep 23, 2026 | 23.34B | 1.36% |
| Sep 22, 2026 | 23.03B | -13.03% |
| Sep 21, 2026 | 26.48B | 9.35% |
| Sep 18, 2026 | 24.21B | 34.46% |
| Sep 17, 2026 | 18.01B | 2.91% |
| Sep 16, 2026 | 17.50B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Suzhou Zelgen Biopharmaceuticals | 29.12B |
| Beijing Tiantan Biological Products | 24.90B |
| Hualan Biological Engineering | 24.35B |
| Acrobiosystems | 23.58B |
| Hebei Changshan Biochemical Pharmaceutical | 21.08B |
| Xiamen Amoytop Biotech | 21.02B |
| Sino Biological,Inc. | 19.34B |
| Yili Chuanning Biotechnology | 18.28B |